Search clinical trials for: Machine learning algorithm

Total 10000 results

Regeneron Pharmaceuticals

Completed

A Study to See How Safe and Tolerable Different Doses of REGN13335 Are When Administered Intravenously (IV) or Subcutaneously (SC) to Healthy Adult Participants

Healthy Volunteers

New Zealand
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines

Varicella

Philippines
ASH Research Collaborative
University of Pennsylvania; American Society of Hematology

Completed

COVID-19 Vaccine Response in Sickle Cell Disease

COVID-19 | Sickle Cell Disease

United States
University Hospital Tuebingen

Completed

Personalized Multi-peptide Vaccination in CLL Patients

Chronic Lymphocytic Leukemia

Germany
Persephone Biosciences

Terminated

Vaccine Observation to Include All Communities for Equitable Science (VOICES)

Vaccine Adverse Reaction | Vaccine Response Impaired

United States
Universitas Padjadjaran
Universiti Sains Malaysia; Biofarma

Completed

Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)

Diabetes Mellitus | Chronic Kidney Diseases | Vaccine Reaction | Influenza

Indonesia
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Completed

Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

China
University of Aarhus

Completed

Expectations About the COVID-19 Vaccines

Vaccine Adverse Reaction

Denmark
The Immunobiological Technology Institute (Bio-Manguinhos)...
Ministry of Health, Brazil

Active, not recruiting

Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)

Immunity | Yellow Fever Vaccine

Brazil
The University of Texas Health Science Center at...

Completed

Host Immune Response to Novel RNA COVID-19 Vaccination

Cancer | COVID-19 Vaccine

United States
Novartis Vaccines

Completed

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

Seasonal Influenza

Italy
Shanghai Zerun Biotechnology Co.,Ltd

Completed

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

HPV Infections

China
University of Kansas Medical Center

Active, not recruiting

To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment (CANINE)

Breast Cancer | Lung Cancer | Melanoma (Skin)

United States
Jiangsu Province Centers for Disease Control and...

Completed

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

Influenza

China
Kanion & Huawe Medicine Co.,Ltd

Terminated

Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients

Obesity

China
Syneos Health

Completed

First-in-Human Study of SRT-015 in Healthy Subjects.

Nonalcoholic Steatohepatitis

Australia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Meningococcal Infections

Finland
National Institute of Allergy and Infectious Diseases...

Completed

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

HIV Infections | Pregnancy | HIV Seronegativity

United States
Assiut University

Unknown

Effects of COVID 19 Vaccine on Egyptian Population

COVID 19 Vaccine
National University Hospital, Singapore
Agency for Science, Technology and Research; National University of Singapore

Unknown

Gestational Immunity for Transfer (GIFT)

Covid19 | Breastfeeding | Vaccine Exposure Via Breast Milk

Singapore
Masaryk University
University of Kiel; University of Giessen; F.D. Roosevelt Teaching Hospital with... and other collaborators

Unknown

Oral Side Effects of COVID-19 Vaccine

Covid19 | Vaccine Adverse Reaction | Oral Manifestations

Czechia, Germany, Slovakia
Bristol-Myers Squibb

Completed

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Mexico, Australia, Colombia, Chile, Peru
University of California, Los Angeles
National Cancer Institute (NCI); University of Colorado, Denver

Completed

HPV IIS Reminder/Recall- New York State

Reminder Systems

United States
Peking University
Shenzhen Kangtai Biological Products Co., LTD; Guangxi Center for Disease Control... and other collaborators

Completed

A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults

Hepatitis B

China
GlaxoSmithKline

Completed

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

HIV Infections | AIDS

Belgium
Bristol-Myers Squibb

Terminated

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Diabetic Kidney Disease

United States, Canada, Denmark, France
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Terminated

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme (Dendr2)

Glioblastoma
GlaxoSmithKline

Completed

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers

Infections, Meningococcal

United States
Public Health England

Completed

The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine

Haemophilus Influenzae Type b
National Institute of Allergy and Infectious Diseases...

Terminated

Development of Immune Globulin Treatment for Avian Flu

Influenza | Infectious Diseases | Avian Flu

United States
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza, Human

United Kingdom
University of Colorado, Denver

Withdrawn

Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine.

Varicella | Transplants
University of Michigan
American College of Allergy, Asthma and Immunology

Completed

Safe Administration of Flu Vaccine to Egg Allergic Children (SAFE)

Egg Allergy

United States
Clinica Universidad de Navarra, Universidad de...

Unknown

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Colorectal Carcinoma | Hepatic Metastasis

Spain
China National Biotec Group Company Limited
Shaanxi Provincial Center for Disease Control and Prevention

Unknown

Comparative Immunogenicity Study of Two Hepatitis A Vaccines

Hepatitis A

China
King's College London
King's College Hospital NHS Trust

Unknown

B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute
Research Institute for Biological Safety Problems
Research Institute of Influenza, Russia; Asfendiyarov Kazakh National Medical...

Completed

Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)

Influenza, Human

Kazakhstan
Baylor Research Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

United States
Novartis Vaccines

Completed

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

Influenza Disease

Italy
GlaxoSmithKline

Completed

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Hepatitis B

Germany
GlaxoSmithKline

Completed

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Hepatitis B

Germany
GlaxoSmithKline

Completed

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Measles | Rubella | Mumps
National Institute of Allergy and Infectious Diseases...

Completed

Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

Smallpox

United States
Jiangsu Province Centers for Disease Control and...
Beijing Institute of Biotechnology; Tianjin Cansino Biotechnology Inc

Completed

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

Ebola Disease

Sierra Leone
Seqirus

Completed

Phase II Study of Pandemic Influenza Vaccine

Influenza

Australia
AGIRx Ltd.

Terminated

Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced Melanoma

Melanoma

Poland
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009

Interpandemic Influenza

Italy
Emory University
Kaiser Permanente

Completed

Vaccine Acceptance in Pregnant Minority Women

Pregnancy

United States
University of Sao Paulo

Completed

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil (HPV)

Infection

Brazil
Icon Genetics GmbH

Completed

Autologous Vaccine for Follicular Lymphoma

Lymphoma, Follicular

United States

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations